Back
EPAM Systems 10K Form
Buy
63
EPAM
EPAM Systems
Last Price:
245.22
Seasonality Move:
8.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | EPAM/EPAM Systems Quarterly |
| 2023-11-03 | 10Q | EPAM/EPAM Systems Quarterly |
| 2023-08-03 | 10Q | EPAM/EPAM Systems Quarterly |
| 2023-05-05 | 10Q | EPAM/EPAM Systems Quarterly |
| 2022-11-04 | 10Q | EPAM/EPAM Systems Quarterly |
| 2022-08-05 | 10Q | EPAM/EPAM Systems Quarterly |
Receive EPAM News And Ratings
See the #1 stock for the next 7 days that we like better than EPAM
EPAM Financial Statistics
Sales & Book Value
| Annual Sales: | $4.69B |
|---|---|
| Cash Flow: | $237M |
| Price / Cash Flow: | 23.73 |
| Annual Sales: | $62.67 |
| Price / Book: | 3.73 |
Profitability
| EPS (TTM): | 7.70000 |
|---|---|
| Net Income (TTM): | $448.79M |
| Gross Margin: | $1.43B |
| Return on Equity: | 13.05% |
| Return on Assets: | 10.4% |
EPAM Systems Earnings Forecast
Key EPAM Systems Financial Ratios
- The Gross Profit Margin over the past 15 years for EPAM is 30.57%.
- The Selling, General & Administrative Expenses for EPAM have been equal to 17.38% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.36% of Operating Income.
- The Net Earning history of EPAM is 8.89% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 10 years.
EPAM Systems Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | IT Services |
| Sector: | Information Technology |
| Current Symbol: | EPAM |
| CUSIP: | 29414B |
| Website: | epam.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 4.56 |
| Quick Ratio: | 4.4 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.06 |
|---|---|
| Forward P/E Ratio: | 20.78 |
EPAM Technical Analysis vs Fundamental Analysis
Buy
63
EPAM Systems (EPAM)
is a Buy
Is EPAM Systems a Buy or a Sell?
-
EPAM Systems stock is rated a Buy
The current EPAM Systems [EPAM] share price is $234.50. The Score for EPAM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.